Generics 1

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Carboplatin manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : Mexico

Clear all

1 products found

carboplatin

Injection 150 mg, 450 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Mexico
GMP approvals
COFEPRIS
Manufacturer #18807
It is a company formed exclusively for the manufacture of highly specialized drugs. The company has the vision to become a worldwide leader based on technical and economic growth, based on the value of our products, technologies, and services. It ensures the supply, availability, and affordability of their products.

Manufacturer usually replies in nan days

Want to see all 1 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Carboplatin Methyl

Carboplatin is a chemotherapy agent used in treating certain sorts of cancer. The parent compound is cisplatin, Carboplatin is a kind of platinum anti-cancer compound. Carboplatin has achieved a significant reputation since its introduction back in the 1980s because it causes fewer side effects than cisplatin.

How does Carboplatin work?

Carcinoid tumors are characterized by cell division that is no longer as organized as in normal tissues. Normal cell stops dividing when they are in contact with cells similar to this, a process is known as contact inhibition. Cancer cells lose this ability. The process of cell division, whether normal or cancerous cells, takes place through the cell cycle. The cell cycle moves from the resting phase, through the phases of active growth, and then to mitosis (mitosis). The ability of chemotherapy to kill cancer cells depends on its ability to stop the cells from dividing. Drugs usually work by damaging RNA or DNA which tells the cell how to copy itself in case of division. Cells die if they’re unable to divide. If the cells divide faster, it is likely the chemotherapy will kill the cells, causing the tumor to shrink. They also induce cell suicide (self-death or programmed cell death). Chemotherapy drugs that affect cells only when they divide are called a specific cell cycle. The scheduling of chemotherapy is determined based on the type of cells, the rate of division, and the time that a particular drug is likely to be effective. This is why chemotherapy is usually given in cycles. Chemotherapy is very powerful at killing rapidly dividing cells. Unfortunately, chemotherapy does not know the difference between cancerous cells and healthy cells. The normal cells will grow again and be healthy but in the meantime, side effects occur. The normal cells most affected by chemotherapy are blood cells, cells of the mouth, stomach, intestines, and hair follicles. Leading to low blood counts, mouth sores, nausea, diarrhea, and/or hair loss. Different medicines may affect different parts of the body. Chemotherapy (anti-tumor drugs) falls into five categories based on how they work to kill cancer. Although these medicines are divided into groups, there is some overlap between some of the specific medicines.

Types of chemotherapy:

Alkylsulfonates: Busulfan. Ethylenimines: Hexamethylmelamine and Thiotepa. Mustard gas derivatives: Cyclophosphamide, Mechlorethamine, Melphalan, Chlorambucil, and Ifosfamide. Metal salts: Cisplatin, Carboplatin, and Oxaliplatin. Hydrazines and Triazines: Dacarbazine, Temozolomide, and Procarbazine. Nitrosoureas: Streptozocin, Lomustine, and Carmustine. Nitrosoureas are unique because, unlike most chemotherapy, they can cross the blood-brain barrier.

Carboplatin Side Effects:

Here are some examples of the side effects that may occur while carboplatin treatment: Diarrhea Nausea and vomiting Loss of appetite and Mouth ulcers Kidney and liver function may also be affected Hearing loss may be noticed, especially in children taking the treatment Hair loss

How much money does Carboplatin cost?

The retail prices per 5ml of 10mg/ml carboplatin injectable solution fall into an approximate range of 8.00 EUR to 12.00 EUR, whereas 60 ml vial of 10mg/ml carboplatin can cost around 60-70 EUR.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of carboplatin offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for carboplatin manufacturers and carboplatin suppliers that you are looking for. These also enable you to check the dossier status of Carboplatin, and the GMP approvals of the different variants of Carboplatin. Also, each manufacturer or supplier product description contains essential information about carboplatin including clinical data, stability zones, countries where carboplatin is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Ivermectin offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that Ivermectin manufacturers have, we qualify their companies before they are onboarded on the platform. This allows us to screen Ivermectin manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation